Advances in neurology.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D005158:Facial Paralysis / Q000188:drug therapy; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy; D009103:Multiple Sclerosis / Q000628:therapy; D009422:Nervous System Diseases / Q000628:therapy*; D010243:Paralysis / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D004295:Dihydroxyphenylalanine; D000324:Adrenocorticotropic Hormone